scholarly article | Q13442814 |
P356 | DOI | 10.1089/GTE.2006.9996 |
P698 | PubMed publication ID | 17394390 |
P2093 | author name string | Wayne W Grody | |
Roger V Lebo | |||
P433 | issue | 1 | |
P921 | main subject | cystic fibrosis | Q178194 |
P304 | page(s) | 11-31 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
P1476 | title | Testing and reporting ACMG cystic fibrosis mutation panel results | |
P478 | volume | 11 |
Q35033414 | Analyzing the most frequent disease loci in targeted patient categories optimizes disease gene identification and test accuracy worldwide |
Q37151115 | Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report |
Q33608587 | Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice |
Q55037100 | Enhancing genomic laboratory reports: A qualitative analysis of provider review. |
Q33856320 | Genetic tests: clinical validity and clinical utility |
Q38135327 | Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors |
Q36843233 | Ordering molecular genetic tests and reporting results: practices in laboratory and clinical settings |
Q36096070 | Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes |
Search more.